Trump Budget Seeks Huge Cuts To Disease Prevention And Medical Research Departments | (Washington Post/To Your Health) May 22, 2017 - The budget is released early, and shows Trump wants big cuts to NIH, CDC and FDA. | Read More >>

Interval Colorectal Cancer Risk Higher in Black Patients | (Medscape Medical News) May 22, 2017 - The risk for interval colorectal cancer (CRC), or CRC that develops after a negative result on a colonoscopy but before the next recommended screening, is much higher in older black patients than in those of any other race or ethnicity, a new study concludes. | Read More >>

CHMP Recommends Against Approving XBiotech's Lead mAb Xilonix for CRC | (Genetic Engineering & Biotechnology News) May 19, 2017 - The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion on XBiotech’s lead product, its human interleukin-1α monoclonal antibody (mAb), and recommended against approval of the mAb in Europe for treating the debilitating symptoms of advanced colorectal cancer (CRC). | Read More >>

IPH4102: Completion of the Dose Escalation Portion Of The Phase I Trial - Data To Be Presented At International Conference On Malignant Lymphoma In June 2017 In Lugano | (Innate Pharma) May 22, 2017 - Complete safety results and updated clinical activity data will be presented at the ICML 2017 in Lugano in June; preparation for cohort expansion portion is Ongoing. | Read More >>

More Women Are Living Longer With Metastatic Breast Cancer, But Questions Remain | (Forbes) May 18, 2017 - Metastatic breast cancer patients represent a significant group within the U.S. population who live with a chronic or terminal condition and stand to benefit from new treatments. | Read More >>

A Small Boston Biotech Is At The Heart Of A Groundbreaking Approach To Tackling Cancer | (Business Insider) May 21, 2017 - On Wednesday, Agios came out with new data on its phase 1/2 trial, which will be presented at the American Society of Clinical Oncology annual conference. | Read More >>

Latest Series of QOPI Certification Program Webinars Kicks Off May 24â€"Register Now | (ASCO in Action) May 19, 2017 - On May 24 at noon (ET), ASCO will host a one-hour webinar for participants to learn more about the Quality Oncology Practice Initiative (QOPI®) Certification Program. | Read More >>

How a Drug Ad Made Its Way Into â€~General Hospital†| (STAT) May 18, 2017 - Incyte’s move to bake a disease-awareness campaign into a TV show looks to be an industry first. | Read More >>

Consumer Reports Ranks Top Sunscreens for 2017 | (WebMD) May 18, 2017 - Consumer Reports magazine tested 58 suncreen products and has made recommendations, following FDA recommendations. | Read More >>

FDA Review Raises Some Serious Questions For Puma, But Shares Rocket Up On Positive Notes | (Endpoints News) May 22, 2017 - Puma Biotechnology will face some tough questions from regulators during Wednesday's long-awaited panel review for its experimental cancer drug neratinib. | Read More >>

A Drink A Day Tied To Higher Breast Cancer Risk, Report Says | (CNN) May 23, 2017 - Researchers have long known that having one too many cocktails might be associated with an increased risk of breast cancer. Now, a new report from the World Cancer Research Fund and the American Institute for Cancer Research reveals just how much of a risk daily drinking might pose for both premenopausal and postmenopausal women. | Read More >>

Erectile Dysfunction Medicines Do Not Cause Melanoma, Analysis of Large Studies Finds | (NYU Langone Medical Center) May 19, 2017 - Use of the erectile dysfunction drug Viagra does not cause the development of melanoma, a deadly form of skin cancer. | Read More >>

Jillella Returns As J. Harold Harrison MD Chair For Medical Oncology | (Augusta University/Jagwire) May 19, 2017 - Dr. Anand P. Jillella returns to the Medical College of Georgia at Augusta University July 1 as the J. Harold Harrison, MD, Distinguished University Chair in Medical Oncology. | Read More >>

One in Five Cancers Diagnosed in the United States Is a Rare Cancer | (ACS) May 19, 2017 - Proportion of rare cancers likely to grow as use of molecular markers increases. | Read More >>

Rise in Lung Adenocarcinoma Linked to Light Cigarette Use | (OSUCCC – James) May 22, 2017 - A new study shows that so-called “light” cigarettes have no health benefits to smokers and have likely contributed to the rise of a certain form of lung cancer that occurs deep in the lungs. | Read More >>

Three More Biosimilar Rituximab Products in Europe | (Medscape Medical News) May 19, 2017 - Three more biosimilar versions of the monoclonal antibody rituximab have been recommended for approval in Europe, having been found to be "highly similar" to the reference product, rituximab (MabThera, Roche). | Read More >>

Study Evaluates Impact of Black Raspberries on Oral Cancer Prevention in Smokers | (OSUCCC – James) May 16, 2017 - Cigarette smokers are needed for a new study to test whether phytochemicals in black raspberries can protect smokers from oral disease and lower their risk of developing oral cancer. | Read More >>

Refusal of the Marketing Authorisation for Masipro (masitinib) | (EMA) May 19, 2017 - On 18 May 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicinal product Masipro, intended for the treatment of systemic mastocytosis. | Read More >>

Lion Biotechnologies Announces First Patient Dosed In Second Cohort Of Ln-144 Phase 2 Trial For Metastatic Melanoma | (Yahoo! Finance) May 19, 2017 - Lion Biotechnologies, Inc., a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that the first patient was dosed in the second cohort of its ongoing Phase 2 trial of LN-144 for the treatment of patients with metastatic melanoma. | Read More >>

Bladder Cancer Drug Receives FDA Approval Based on Research Led by NYU Langone | (NYU Langone Medical Center) May 19, 2017 - The United States Food and Drug Administration (FDA) has granted accelerated approval to a second drug in less than a month for first-line treatment for advanced bladder cancer—again based on clinical trial findings from the same researcher from NYU Langone’s Perlmutter Cancer Center. | Read More >>